Simplex Trading, LLC Lava Therapeutics Nv Transaction History
Simplex Trading, LLC
- $2.98 Billion
- Q2 2024
A detailed history of Simplex Trading, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Simplex Trading, LLC holds 226 shares of LVTX stock, worth $379. This represents 0.0% of its overall portfolio holdings.
Number of Shares
226
Previous 2,589
91.27%
Holding current value
$379
Previous $8,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
85.8KPut Options Held
36.8K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.48 Million0.24% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.3 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$617,5370.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$188,8970.0% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$146,8260.08% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $43.3M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...